advertisement
Journal of Ocular Pharmacology and Therapeutics 9
Showing records 1 to 9 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics25836 Meta-analysis of 24-h intraocular pressure fluctuation studies and the efficacy of glaucoma medicines
Stewart WC; Konstas AGP; Kruft B; Mathis HM; Stewart JA
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 175-180
25831 Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma
Chen C-H; Lai I-C; Wu P-C; Chen Y-J; Chen Y-H; Lee J-J; Liu Y-C; Kuo H-K
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 111-118
25830 Copolymer-1 immunization reduces damage in retinal ganglion cells under high intraocular pressure through altering the expression of retinal neurotrophins
Yang B; Shan L; Song W; Xiao Z; Shi L; Yuan H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 11-19
25839 A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma
Borghi V; Bastia E; Guzzetta M; Chiroli V; Toris CB; Batugo MR; Carreiro ST; Chong WKM; Gale DC; Kucera DJ
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 125-131
25834 Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN((registered trademark)) or TRAVATAN((registered trademark))
Faulkner R; Sharif NA; Orr S; Sall K; DuBiner H; Whitson JT; Moster M; Craven ER; Curtis M; Pailliotet C
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 147-156
25828 A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of tafluprost compared with latanoprost
Traverso CE; Ropo A; Papadia M; Uusitalo H
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 97-104
25832 A pilot study for the effects of donepezil therapy on cerebral and optic nerve head blood flow, visual field defect in normal-tension glaucoma
Yoshida Y; Sugiyama T; Utsunomiya K; Ogura Y; Ikeda T
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 187-192
25833 Persistent ocular hypertension following intravitreal bevacizumab and ranibizumab injections
Adelman RA; Zheng Q; Mayer HR
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 105-110
25838 Use of 5-fluorouracil injections to reduce the risk of trabeculectomy bleb failure after cataract surgery
Shahid H; Salmon JF
Journal of Ocular Pharmacology and Therapeutics 2010; 26: 119-123
